Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Total Non-Current Liabilities (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Total Non-Current Liabilities for 17 consecutive years, with $2.4 billion as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities changed 0.36% to $2.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 billion through Dec 2025, changed 0.36% year-over-year, with the annual reading at $2.4 billion for FY2025, 0.36% changed from the prior year.
  • Total Non-Current Liabilities hit $2.4 billion in Q4 2025 for Integra Lifesciences Holdings, down from $2.4 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $2.4 billion in Q2 2024 to a low of $1.9 billion in Q1 2023.
  • Historically, Total Non-Current Liabilities has averaged $2.1 billion across 5 years, with a median of $2.0 billion in 2022.
  • Biggest five-year swings in Total Non-Current Liabilities: decreased 4.66% in 2022 and later grew 22.89% in 2024.
  • Year by year, Total Non-Current Liabilities stood at $2.0 billion in 2021, then rose by 3.81% to $2.1 billion in 2022, then decreased by 2.85% to $2.0 billion in 2023, then grew by 17.64% to $2.3 billion in 2024, then increased by 0.36% to $2.4 billion in 2025.
  • Business Quant data shows Total Non-Current Liabilities for IART at $2.4 billion in Q4 2025, $2.4 billion in Q3 2025, and $2.4 billion in Q2 2025.